Article Details

FY2023 EPS Estimates for Sierra Oncology, Inc. (NASDAQ:SRRA) Decreased by Analyst

Retrieved on: 2020-12-21 07:41:15

Tags for this article:

Click the tags to see associated articles and topics

FY2023 EPS Estimates for Sierra Oncology, Inc. (NASDAQ:SRRA) Decreased by Analyst. View article details on hiswai:

Excerpt

The biotechnology company reported ($1.39) EPS for the quarter, topping analysts' consensus estimates of ($1.64) by $0.25. A number of other analysts ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo